Enno Christophers

Enno Christophers's AcademicInfluence.com Rankings

Enno Christophers

Philosophy

#3979

World Rank

#6333

Historical Rank

Logic

#1544

World Rank

#2322

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Enno Christophers Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Enno Christophers is emeritus professor of dermatology and venereology at the University of Kiel, Germany. He was appointed editor-in-chief of the Archives of Dermatological Research in 1975. In 1982 he delivered the Kung Sun Oh lecture, on the topic of psoriasis.

(See a Problem?)

Enno Christophers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Severity Scoring of Atopic Dermatitis: The SCORAD Index (1993) (1829)
A peptide antibiotic from human skin (1997) (1359)
Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* (2001) (1328)
Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. (1985) (931)
Psoriasis − epidemiology and clinical spectrum (2001) (886)
PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM. (1963) (756)
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils (1992) (721)
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis (2006) (675)
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection (2005) (632)
Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. (2006) (576)
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity (2012) (555)
Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. (1987) (520)
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. (1992) (478)
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease (2003) (441)
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. (1997) (425)
Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. (1990) (413)
Disease concomitance in psoriasis. (1995) (382)
Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis (2000) (372)
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. (2003) (361)
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. (2003) (353)
Epidemiology and comorbidity of psoriasis in children (2010) (338)
IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. (1998) (332)
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. (2008) (283)
A classification of psoriasis vulgaris according to phenotype (2007) (278)
What is the 'true' function of skin? (2002) (264)
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. (2000) (262)
Comorbidities in psoriasis (2006) (258)
Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. (1986) (229)
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis (2001) (219)
Biological therapies in the systemic management of psoriasis: International Consensus Conference (2004) (214)
A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. (2002) (201)
ORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASIS The European PUVA Study: a Cooperative Study among 18 European Centres (1981) (199)
The genetics of psoriasis 2001: the odyssey continues. (2001) (198)
Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy (1997) (198)
S100B Protein Detection in Serum Is a Significant Prognostic Factor in Metastatic Melanoma (1999) (183)
Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. (1989) (183)
Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. (1998) (171)
Cellular architecture of the stratum corneum. (1971) (164)
IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. (1990) (162)
Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis (2006) (162)
Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. (1991) (152)
The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics (2010) (150)
Skin tumors in the European PUVA Study (1987) (144)
Oral lichenoid reactions associated with amalgam: improvement after amalgam removal (2003) (138)
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases (2001) (138)
Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). (1988) (132)
Neutrophil-activating proteins in psoriasis. (1992) (131)
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. (1998) (130)
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. (1997) (130)
Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. (2002) (129)
Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. (1997) (128)
Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil- activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity (1990) (126)
ω-3 Fatty acid–based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial (1998) (125)
Contrasting disease patterns in psoriasis and atopic dermatitis (2004) (125)
Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema (2015) (119)
Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. (1996) (115)
VISUALIZATION OF THE CELL LAYERS OF THE STRATUM CORNEUM. (1964) (111)
Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. (1999) (107)
The CXC receptor 2 is overexpressed in psoriatic epidermis. (1998) (104)
Bimodal immune activation in psoriasis (2014) (97)
Antileukoprotease Inhibits Stratum Corneum Chymotryptic Enzyme (1996) (95)
Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients (2003) (95)
Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. (1988) (94)
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. (2000) (93)
Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation (1983) (93)
Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. (1997) (91)
Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study. (1992) (91)
Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. (1997) (89)
Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. (1992) (85)
Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. (2000) (85)
The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. (2003) (84)
Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families (1998) (83)
Importance of human papillomaviruses for the development of skin cancer. (2001) (83)
Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study. (2004) (81)
The immunopathology of psoriasis. (1996) (80)
Growth stimulation of cultured postembryonic epidermal cells by vitamin A acid. (1974) (79)
Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. (1991) (79)
Corneodesmosin gene polymorphism demonstrates strong linkage disequilibrium with HLA and association with psoriasis vulgaris. (1999) (79)
Mast cells and macrophages in early relapsing psoriasis (2004) (71)
Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. (1995) (69)
Low prevalence of the intrinsic form of atopic dermatitis among adult patients (2006) (69)
Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. (1996) (69)
Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus (2011) (68)
Complete remission of a radio‐resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin (2002) (66)
Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study. (1990) (65)
Clearing of Pyoderma gangrenosum by intralesional cyclosporin A (1991) (65)
Differential Sensitivities of Purified Human Eosinophils and Neutrophils to Defined Chemotaxins (1989) (65)
Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: Results of a multicenter study (1995) (64)
Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany (2005) (63)
Association of rare human papillomavirus types with genital premalignant and malignant lesions. (1998) (63)
Analysis of phenotypic variation in psoriasis as a function of age at onset and family history (2002) (62)
Role of eosinophil‐chemotactic C‐C chemokines in cutaneous inflammation (1996) (61)
Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. (1996) (60)
Treatment of severe psoriasis with anti-CD25 monoclonal antibodies. (2000) (59)
The inflammatory infiltrate in psoriasis. (1995) (58)
Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression. (1997) (58)
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. (1998) (57)
Effectiveness of skin cancer screening programmes (2012) (57)
Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis (1978) (57)
MECHANISMS OF PARAKERATOSIS (1970) (57)
Immune response profiles in human skin (2007) (56)
Topical Calcipotriol plus Oral Fumaric Acid Is More Effective and Faster Acting than Oral Fumaric Acid Monotherapy in the Treatment of Severe Chronic Plaque Psoriasis vulgaris (2002) (56)
Of genes and antigens: the inheritance of psoriasis. (1994) (56)
Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. (2001) (56)
Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. (2002) (56)
Linkage disequilibrium analysis of familial psoriasis: identification of multiple disease-associated MHC haplotypes. (1999) (55)
Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. (1987) (55)
IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses. (1981) (54)
Skin diseases following organ transplantation--risk factors and new therapeutic approaches. (2001) (54)
Neutrophil-Activating Peptide 1/Interleukin 8 (1991) (54)
Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. (1989) (53)
Structural aspects of initial psoriatic lesions (2004) (52)
Psoriasis type I and II as subtypes of nonpustular psoriasis. (1992) (52)
Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. (1995) (52)
Eruptive vellus hair cysts and steatocystoma multiplex. Variants of one entity? (1996) (51)
Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients. (2001) (50)
Calcitriol 3 µg g−1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study (2001) (50)
Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self‐activated serum (1980) (50)
Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients. (2000) (50)
The formation of epidermal cell columns. (1974) (50)
Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene-alpha demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis. (2002) (48)
Body-Weight-Independent Dosing of Cyclosporine Micro-Emulsion and Three Times Weekly Maintenance Regimen in Severe Psoriasis (2002) (48)
Cyclosporine in Severe Psoriasis (2001) (48)
Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblasts. (1995) (46)
Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid. (1990) (46)
Initial events in psoriasis: quantitative assessment * (1973) (46)
Dominant sex‐linked inherited chondrodysplasia punctata: a distinct type of chondrodysplasia punctata (1980) (46)
Differential formation of desmosomes and hemidesmosomes in epidermal cell cultures treated with retinoic acid (1975) (46)
Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils. (1985) (45)
Dose‐effects of 8‐methoxypsoralen and UVA in cultured human lymphocytes (1978) (44)
Frequency and Spectrum of HPV Types Detected in Cutaneous Squamous-Cell Carcinomas Depend on the HPV Detection System: A Comparison of Four PCR Assays (2000) (43)
Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. (1989) (43)
Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis (2000) (43)
Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia (2001) (42)
Generalized atrophic benign epidermolysis bullosa in 2 siblings complicated by multiple squamous cell carcinomas. (1998) (42)
Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis (1983) (42)
Urticarial and anaphylactoid reactions following ethanol intake (1995) (41)
Renewal rate of human sebaceous glands. (1974) (41)
The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review (2006) (41)
Cercarial dermatitis contracted via contact with an aquarium: case report and review (2001) (41)
A family study of atopic dermatitis (2004) (40)
Interleukin-8 plays its role at local level in psoriasis vulgaris. (1999) (40)
Identification of DNA Sequences of Both Genital and Cutaneous HPV Types in a Small Number of Keratoacanthomas of Nonimmunosuppressed Patients (1999) (39)
Leiomyomatosis cutis et uteri. (1979) (39)
Antileukoprotease in psoriatic scales. (1993) (39)
Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study (2013) (39)
“Keratolytic” effect of salicylic acid (1977) (38)
Lymphoproliferative Diseases of the Skin (1982) (38)
Selective action of hydrocortisone on postmitotic epidermal cells in vivo. (1976) (38)
Severity, heterogeneity and systemic inflammation in psoriasis (2019) (36)
Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblasts. (1998) (36)
A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. (1988) (36)
Lymphocyte activation by streptococcal antigens in psoriasis (1977) (34)
The architecture of stratum corneum after wounding. (1971) (34)
Explaining phenotype heterogeneity in patients with psoriasis (2007) (33)
[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. (1967) (33)
Effects of vitamin A acid in skin: in vivo and in vitro studies. (1975) (33)
Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes. (1988) (33)
Psoriasis scales contain C5a as the predominant chemotaxin for monocyte‐derived dendritic cells (2001) (32)
Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association. (2005) (32)
Patient subgroups and the inflammatory pattern in psoriasis. (1989) (32)
Formation of the acrosyringium. (1973) (32)
Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor. (1994) (32)
[Liberation of human leukocyte elastase by hypertonic saline baths in psoriasis]. (1989) (32)
Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. (2007) (31)
Correlation between column formation, thickness and rate of new cell production in guinea pig epidermis (1972) (31)
Time- and stimulus-dependent secretion of NAP-1/IL-8 by human fibroblasts and endothelial cells. (1993) (31)
Lichenoid reactions of murine mucosa associated with amalgam (2003) (31)
Variations in the HCR (Pg8) gene are unlikely to be causal for familial psoriasis. (2001) (31)
IL-4 Induces Eotaxin in Human Dermal Fibroblasts (1999) (31)
Transient absence of C5a-specific neutrophil function in inflammatory disorders of the skin. (1985) (30)
Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. (2002) (29)
Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage (2005) (29)
Enzyme release by Trichophyton rubrum depends on nutritional conditions (1991) (28)
Topical Corticosteroid Therapy: A Novel Approach to Safer Drugs (1988) (27)
Quadrant distribution of dysplastic nevus syndrome. (1988) (27)
Regional variations in mouse skin : Quantitation of epidermal compartments in two different body sites (1972) (27)
Azelaic acid has antimycotic properties in vitro. (1993) (25)
Photoinactivation and recovery in skin fibroblasts after formation of mono- and bifunctional adducts by furocoumarins-plus-UVA. (1980) (25)
Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP. (1989) (25)
[A new method for visualization of the stratum corneum]. (1970) (25)
Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis. (2002) (25)
CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association (2006) (24)
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. (1987) (24)
Positive patch tests with a dermatophagoides mix relate to an increased responsiveness to standard patch test allergens (2002) (23)
[The columnar structure of the epidermis. Possible mechanism of differentiation]. (1971) (23)
Metabolism of arachidonic acid by human epidermal cells depends upon maturational stage. (1991) (23)
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin‐4 stimulation (2011) (23)
Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA. (1979) (23)
Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study. (1995) (22)
[Skin diseases in organ transplant patients]. (2002) (22)
Chemotactic Responsiveness of Eosinophils Isolated from Patients with Inflammatory Skin Diseases (1989) (22)
PSORIATIC HYPERPLASIA: SOME MEASUREMENTS (1970) (22)
Diabetes Mellitus in Cancer Patients Treated with Combination Interleukin 2 and α-Interferon (1995) (21)
Stimulation der epidermalen DNS-Synthese durch Vitamin A-Säure (2004) (21)
The biology of NAP-1/IL-8, a neutrophil-activating cytokine. (1992) (21)
Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi. (2005) (21)
Thrombin and fibrin-induced growth of fibroblasts: Role in wound repair and thrombus organization (1979) (21)
Genomic organization, sequence analysis and transcriptional regulation of the human MCP-4 chemokine gene (SCYA13) in dermal fibroblasts: a comparison to other eosinophilic beta-chemokines. (1999) (21)
Systemic factors influencing epidermal mitosis. (1972) (20)
Efficacy and tolerability of multiple‐dose SDZ IMM 125 in patients with severe psoriasis (1995) (19)
Monoclonal cryo-antifibrinogenemia. (1996) (19)
Dermatophytes contain a novel lipid-like leukocyte activator. (1996) (19)
Antileukoprotease Inhibits Stratum Corneum Chymotryptic Enzyme EVIDENCE FOR A REGULATIVE FUNCTION IN DESQUAMATION* (1996) (19)
[CONTRIBUTION TO THE EPIDEMIOLOGY OF WARTS]. (1964) (19)
Alefacept in the Treatment of Psoriasis in Patients for Whom Conventional Therapies Are Inadequate (2005) (19)
Lesional elastase activity in psoriasis (1995) (18)
Photoinactivation of cultured skin fibroblasts by sublethal doses of 8-methoxypsoralen and long wave ultraviolet light. (1978) (18)
Proliferative cells in the human sebaceous gland. Labelling index and regional variations. (1971) (18)
Treatment of psoriasis with polyethylene sheet bath PUVA. (1996) (18)
Inhibition of dermatophytes by optical brighteners (2003) (17)
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohort. (2007) (17)
[Therapy of psoriasis]. (1983) (16)
Therapy of psoriasis with retinoid plus PUVA: Clinical and histologic data (1979) (16)
Periodontitis and risk of psoriasis: another comorbidity (2017) (15)
Quantification of melanoma-associated molecules in plasma/serum of melanoma patients. (2001) (15)
Kinetics and structural organisation of the epidermis. (1976) (15)
Foil bath PUVA in the treatment of prurigo simplex subacuta. (1996) (14)
Cell transition in human sebaceous glands. (1971) (14)
Sentinel node biopsy in melanoma (2001) (14)
[Therapy of alopecia areata with diphenylcyclopropenone]. (1985) (13)
Guttate and plaque psoriasis. (1995) (13)
Inhibition of human monocyte functions by anthralin (1992) (13)
[Treatment of scabies with special consideration of the approach in infancy, pregnancy and while nursing]. (2000) (13)
Production of 15‐Hydroxyeicosatetraenoic Acid by Purified Human Eosinophils and Neutrophils (1990) (13)
Identification of different charged species of a human monocyte derived neutrophil activating peptide (MONAP). (1988) (13)
From melanotic to amelanotic lentigo maligna: an aggressive variant presenting as an inflammatory lesion (1997) (13)
Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet-factor 4. (1990) (12)
Type I and type II psoriasis show a similar usage of T-cell receptor variable regions. (1991) (12)
[Safety margins in the excision of primary malignant melanoma. Proposals based on controlled clinical trials]. (2001) (12)
S100A2 coding sequence polymorphism: characterization and lack of association with psoriasis (2001) (12)
Mesna side effects which imitate vasculitis (1992) (12)
Nevoid follicular epidermolytic hyperkeratosis. (1975) (12)
In vitro-effects of vitamin A acid on cultured fibroblasts, lymphocytes and epidermal cells: a comparative study. (1974) (12)
Risk of skin tumors in psoralen- and ultraviolet A-treated patients. (1984) (12)
Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A. (1991) (12)
Clinical evaluation of 5-S-cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma (2002) (12)
Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma. (1999) (12)
Inhibition of proteinase 3 activity by peptides derived from human epidermis. (1993) (11)
Impact of early vs. late disease onset on treatment response to etanercept in patients with psoriasis (2015) (11)
Transendothelial cell diapedesis of neutrophils in inflamed human skin (2004) (11)
[On the behavior of autoantibodies in bullous pemphigoid]. (1967) (11)
EPIDERMAL CELL REPLACEMENT: TOPOGRAPHICAL VARIATIONS IN ALBINO GUINEA‐PIG SKIN (1969) (11)
Pro- and anti-inflammatory cytokines in primary systemic vasculitis. (1993) (11)
Atopic dermatitis: influence of bacterial infections on human monocyte and neutrophil granulocyte functional activities. (1988) (11)
What’s new in psoriasis (2000) (11)
Targeting T‐cell subsets to achieve remission (2003) (10)
Hair Root Pattern in Male Pattern Alopecia (1968) (10)
Mitogenic Properties of Aromatic Retinoids: in vivo and in vitro Effects on Epidermal Cells (1981) (10)
Plasma lactoferrin reflects neutrophil activation in psoriasis (1988) (10)
Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts (2009) (10)
Occupational (photo)allergic contact dermatitis from azaperone in a piglet dealer (1991) (10)
Multiple myeloma first presenting as cutaneous plasmacytoma. (1996) (9)
[Neutrophil granulocyte chemotaxis and psoriasis]. (1981) (9)
Antiprotease activity in urine of patients with inflammatory skin disorders. (1995) (9)
DER MERKEL-ZELL-TUMOR DER HAUT (2008) (9)
[On the incorporation of 35S-labelled sulfate in the skin in psoriasis (in vitro). Contribution to the problem of epidermal acid mucopolysaccharides]. (1966) (9)
[Merkel cell carcinoma: follow-up of 10 patients. Current diagnosis and therapy]. (1997) (9)
Allergic reactions to mesna (1991) (8)
Topical tiacrilast, a potent mast cell degranulation inhibitor, does not improve adult atopic eczema. (1993) (8)
Nodular balloon cell component in a cutaneous melanoma of the superficial spreading type. (1996) (8)
Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferon. (1995) (8)
Infiltrating Neutrophils Differ from Circulating Neutrophils when Stimulated with C5a, NAP‐l/IL‐8, LTB4 and FMLP (1992) (7)
Candida albicans grown in glucose-free media contains serum-independent chemotactic activity. (1992) (7)
Serum‐independent neutrophil chemotaxins in the yeast phase of Candida, albicans (1991) (7)
Psoriasis: Mechanisms and entry points for possible therapeutic interventions (1996) (7)
Hypertriglyceridemia in patients with psoriasis treated with cyclosporine. (1992) (7)
Why hair turns green. (1993) (7)
Modulation of Human Monocyte Functions during Acute Bacterial Infection (1988) (7)
Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP) (2003) (7)
Repeatable acute rhabdomyolysis with multiple organ dysfunction because of interferon α and dacarbazine treatment in metastatic melanoma (2001) (7)
Clinical, Morphological and Functional Aspects of Cutaneous T Cell Lymphomas (1982) (7)
Leukocyte chemotaxis after in vitro treatment with 8-Methoxypsoralen and UVA (1977) (7)
[DNA-synthesis and hyperplasia of the epidermis after stripping and application of ointments]. (1968) (7)
Interleukin-8 immunoreactivity in malignant tumours of the skin. (1996) (7)
Pigmentary lesions after PUVA treatment. (1984) (7)
Innovative balneotherapy with reduced bath solution volumes: foil baths (1994) (6)
Evolution of innate defense in human skin (2021) (6)
The role of the Duffy antigen-related chemokine receptor in psoriasis vulgaris. (2002) (6)
[Proliferating trichilemmal tumor]. (1981) (6)
Atopic dermatitis versus infantile eczema. (2001) (6)
[Postphotochemotherapeutic eruptive lentigines]. (1983) (6)
Eczema infantum and its prognosis. (2004) (6)
Linkage disequilibrium analysis of familial (1999) (5)
Skin Bromide Content and Bromide Excretion in Bromoderma Tuberosum (1976) (5)
HLA-related lymphocyte responsiveness in psoriasis. (1983) (5)
Psoriasis: heterogeneity, innate immunity and comorbidities (2012) (5)
[Proliferating tricholemmal cysts]. (1973) (5)
Inhibitor of the release of mast cell mediators does not improve the psoriatic plaque. (1995) (5)
Functional changes of neutrophil responses in relapsing acne fulminans. (1985) (5)
[Multiple melanoma in xeroderma pigmentosum]. (1994) (4)
Platelets secrete an eosinophil-chemotactic cytokine which is a member of the C-C-chemokine family. (1993) (4)
Eosinophilic diseases of the skin. (2000) (4)
[Surgical and adjuvant drug therapy in head and neck cutaneous melanoma]. (2000) (4)
[Malignant melanoma in the area of the head and neck]. (1986) (4)
[Porokeratosis plantaris, palmaris et disseminata]. (1985) (4)
[Familial subungual pterygias]. (1975) (4)
[Regulatory factors of the psoriatic skin reaction]. (1989) (4)
No reason to stand still (2003) (4)
[Sweet's syndrome after T-lymphoblastic lymphoma and before the manifestation of a secondary acute myeloid leukemia]. (2008) (4)
Leukocytes and Skin Disease: Conflicting Patterns of Inflammation in Atopic Dermatitis and Psoriasis (1986) (4)
Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann corneal dystrophy (1997) (4)
[Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors]. (2008) (4)
[The effect of cantharidin on the epidermal incorporation of 35S labeled sulfate]. (1967) (4)
In Vitro-effects of vitamin A acid (1974) (4)
[Cryofibrinogenemia--successful therapy by decreasing fibrinogen]. (1991) (4)
C5a-specific modulation of phagocyte functions in patients with localized bacterial infections. (1987) (4)
Effects of cyclosporine A treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro. (1988) (4)
Fluorescein-isothiocyanate as a stain for keratinizing epithelia (2004) (4)
[Mutilating subungual warts. Healing through methotrexate]. (1973) (4)
[Pathogenetic aspects of psoriasis]. (1972) (4)
Defining psoriasis subtypes: features of severe psoriasis and associated diseases (2007) (3)
[Innovative balneotherapy with reduced bath volume: foil baths]. (1994) (3)
[Dextran-therapy in diffuse (progressive) scleroderma]. (1970) (3)
Erythema elevatum diutinum associated with severe oropharyngeal ulceration and pyoderma gangrenosum (2018) (3)
Soluble CD 30 Plasma Concentrations Correlate with Disease Activity in Patients with Atopic Dermatitis (2002) (3)
Pustular skin diseases refl ect distinct innate defense pathways (2008) (3)
Simultaneous Onset of Psoriasis Vulgaris in Monozygotic Twins (2001) (3)
[Growth dynamics of epidermis and papillary bodies after local applications of vitamin A acid. Biometrical studies of the guinea pig ear]. (1968) (3)
Prevention initiative for dermatological malignancies: where do we stand? (2012) (3)
[Erythema necroticans migrans without glucagonoma]. (1994) (3)
[Action mechanism of vitamin A acid (tretinoin)]. (1971) (3)
[Von Recklinghausen neurofibromatosis and dermal melanocytic nevi]. (1995) (3)
Association of lymphocytic colitis with linear IgA dermatosis. (1999) (3)
Metabolism and urinary excretion of elafin, a specific inhibitor of human leukocyte elastase (1993) (2)
Mapping of psoriasis susceptibility locus to a 330 kb region of centromeric HLA class I (6p21.3) by linkage disequilibrium analysis (1998) (2)
[Exanthema in childhood. I: Exanthema induced by viral infections]. (1999) (2)
The MHC genes in psoriasis (2005) (2)
125 Years of Archives of Dermatological Research (1994) (2)
Genotyping psoriasis. (2003) (2)
Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis. (1983) (2)
Plasmapheresis and Pulse Cyclophosphamide Therapy in Pemphigus Vulgaris: A Novelty or a Reappraisal?-Reply (1988) (2)
Some observations on stratum corneum. (1982) (2)
[Neutrophilic granulocytes and the skin]. (1994) (2)
[Antipruritic therapy in atopic eczema]. (2001) (2)
Growth characteristics of skin fibroblasts and 3T3 cells entrapped by polymerizing fibrin (2007) (2)
[LILAs (lipid-like leukocyte activators) isolated from Saccharomyces cerevisiae induce calcium mobilization in human neutrophilic granulocytes[]. (1996) (2)
Protein-Truncation Mutations in the RP 2 Gene in a North American Cohort of Families with X-Linked Retinitis Pigmentosa (1999) (2)
Giant Primary Melanoma With No Apparent Metastases: A Report of 2 Cases (2017) (2)
[Leukocyte response]. (1985) (2)
[Side-effects of interferon therapy in their management]. (2000) (2)
[Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis]. (2002) (2)
Human Leukocyte chemotaxis induced by gluten (1977) (2)
["Ambulatory balneo-phototherapy" trial model]. (1994) (2)
Etanercept, a TNF Antagonist for Treatment of Psoriatic Arthritis and Psoriasis (2003) (2)
Lymphoproliferative Disease of the Skin (1982) (2)
[Oral exposure testing in non-aspirin-induced analgesic intolerance]. (1996) (2)
[The pseudo-Ainhum syndrome]. (1977) (2)
[Tinea caused by Trichophyton equinum]. (1998) (2)
Dose-effects of 8-methoxypsoralen and long wave UV-light in 3T3 cells: evaluation of a phototoxic index (1979) (1)
Architectural considerations of epidermal growth. (1980) (1)
Sangtec S100?? is a reliable serum marker for metastatic melanoma: 191 (1997) (1)
Action spectra for 8-methoxypsoralen and 3-carbethoxypsoralen in skin fibroblasts in vitro (2004) (1)
[Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration]. (1994) (1)
Skin Cancer Prevention on Germany (1997) (1)
Multiple painful leiomyomas of the skin: a novel therapy with sympathicolysis? (1997) (1)
[Exanthema in childhood. 2: Bacterial and drug-induced exanthema, exanthema after bone marrow transplantation, exanthema of uncertain etiopathogenesis]. (1999) (1)
Regulatory functions of antileukoprotease in the process of desquamation of human skin (1998) (1)
[Contact allergy caused by poison ivy (Toxicodendron spp]. (2001) (1)
[Allergic delayed reactions of the skin: the role of the antigen histotopy]. (1976) (1)
Corneodesmosin gene polymorphism (1999) (1)
Studies on arachidonate 15-lipoxygenase activities of human eosinophils and neutrophils (1990) (1)
PROGRESSION OF MYCOSIS FUNGOIDES DURING CIMETIDINE THERAPY (1985) (1)
[On DNA synthesis time in the human epidermis]. (1967) (1)
[Stimulation of epidermal DNA syntgesis through vitamin A acid]. (1968) (1)
[Chronic urticaria and Helicobacter pylori]. (1996) (1)
[Diagnosis of psoriasis]. (2008) (1)
Recombinant Human Tumour Necrosis Factor β (Lymphotoxin) Lacks Chemotactic Activity for Human Peripheral Blood Neutrophils, Monocytes, and T Cells (1989) (1)
Combined segregation and linkage analysis of HLA markers in familial psoriasis (2002) (1)
Contents, Vol. 104, Supplement 1, 1994 (1994) (1)
Reply to Leder and Hodge (1999) (1)
Decreased releasability of basophils from patients with cold urticaria after cold exposure. (1989) (1)
Morphological changes in polymorphonuclear leucocytes (PMN) with and without chemotaxic stimulation are modulated by ferritin-labelled lectins (1984) (1)
Selective T‐cell targeting in psoriasis: a novel approach to improve clinical outcomes (2003) (1)
Psoriasis: clinical spectrum and classification (2011) (1)
[Dramatic remission of a multiple metastasized melanoma caused by chemo-immunotherapy]. (1993) (1)
Cutaneous inflakmation mediated by intradermal injection of rantes and FMLP: Ultrastructural and immunohistological features (1994) (1)
PUVA responses in skin disease--the lack of known target sites. (1986) (1)
[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. (1967) (1)
Growth characteristics of skin fibroblasts and 3T3 cells entrapped by polymerizing fibrin (1979) (1)
Psoriasis: a continuing challenge for phototherapy. (1986) (1)
[Malignant melanoma in adolescents]. (1995) (1)
[Cryofibrinogenemia caused by monoclonal anti-fibrinogen antibodies]. (1996) (1)
[Concomitant manifestation of neurodermatitis and psoriasis]. (1992) (1)
DNA-based typing of HLA-Cw6, a human leukocyte antigen with increased frequency in type 1 psoriasis (1994) (1)
What's newWhat's new in European dermatological treatment (1998) (1)
[Ear lobe granulomas]. (1982) (1)
29 Serum S100β detection predicts therapeutic outcome in metastatic melanoma (1997) (1)
Satellite Symposium at the 7th Congress of the European Academy of Dermatology and Venereology, Nice, October 9, 1998 (1999) (1)
Subject Index Vol. 56, 1999 (1999) (0)
Tumor necrosis factor-α and interleukin-1 induce rantes mRNA expression in human dermal fibroblasts (1994) (0)
Treatment of Autoimmune Disorders (2003) (0)
Genital HPVs in premalignant and malignant skin lesions (1998) (0)
Skin tumors in organ transplantated patients (1998) (0)
Tyrosinase Fails as an Early Melanoma Progression Marker (1996) (0)
Abstracts of the 6th International Psoriasis Symposium (Part 3 of 3) (1995) (0)
Pustular diseases and keratinocyte–myeloid synergy (2022) (0)
[Psoriasiforme reaction of the guinea-pig epidermis after topical application of vitamin A-acid]. (1969) (0)
Management of generalised pustular psoriasis (2001) (0)
A time of change (2004) (0)
Novel Dermatologic Uses of the Immune Response Modifier Imiquimod 5% Cream (2002) (0)
[Dermatozoic syndrome ("dermatozoic delusion")]. (1969) (0)
Classic Disseminated Histoplasmosis with Cutaneous Involvement (2015) (0)
Interleukin 8 receptor B in inflammatory dermatoses (1998) (0)
Chemoimmunotherapy in metastatic melanoma: 410 (1997) (0)
[Proceedings of dermatologic societies. Union of Schleswig-Holstein Dermatologists. 28th scientific session 19 Jan. 1977 at the Dermatological Clinic of the Christian Albrecht University Kiel]. (1978) (0)
[Fine-structure examination and prognosis in malignant melanoma]. (1972) (0)
A Review of Systemic Retinoid Therapy for Acne and Related Conditions (2004) (0)
Abstracts of the 6th International Psoriasis Symposium (Part 2 of 3) (1995) (0)
Vol. 56, 1999 (1999) (0)
Need for epidemiologic studies of skin disease. (1986) (0)
What does epidemiology tell us about disease mechanisms in psoriasis? (2000) (0)
[Effects of vitamin A-acid and corticosteroids on guinea pig epidermis (autoradiographical and biochemical investigations)]. (1972) (0)
TIME COURSE STUDIES OF NAP-1 IL-8 IMMUNO-REACTIVITY IN PSORIATIC SKIN USING MONOCLONAL ANTI NAP-1 IL-8 ANTIBODIES (1992) (0)
Acknowledgement of referees (1999) (0)
[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. (1970) (0)
7.3 Nagelpsoriasis (2002) (0)
ILDS Newsletter No. 34 (2015) (0)
Subject Index Vol. 205, 2002 (2002) (0)
Cyclic expression and length polymorphism of interleukin-8 mRNA in human keratinocytes upon stimulation with tumor necrosis factor-α (1994) (0)
Subgroups of patients with atopic dermatitis showing different IgE levels (1990) (0)
Neutrophil-activating chemokines in psoriasis (1993) (0)
PMN migration in psoriasis (1988) (0)
Role of Polymorphonuclear Leukocyte chemotaxis in Psoriasis* (2019) (0)
The epidermis disease : based on the proceedings of the European Society for Dermatological Research Symposium, held at the Welsh National School of Medicine, Cardiff, on April 18-20, 1979 (1981) (0)
In Memoriam Professor Dr. Dr. h. c. mult. Otto Braun‐Falco (2018) (0)
The chemokine interleukin-8 plays its role at local level in dermal inflammatory processes (1998) (0)
Optimized detection of 5-S-cysteinyldopa (5-S-CD) in serum of melanoma patients: A new marker of metastatic (1997) (0)
Professor Dr. Helmut H. Wolff (2007) (0)
The yeast Saccharomyces cerevisae contains various chemically distinct lipid-like leukocyte activators (1998) (0)
PL002 Recent advances in psoriasis (1997) (0)
[Autoradiographic analysis of the postmitotic cell transitions in the epidermis]. (1970) (0)
Rantes peptide is produced and released by human dermal fibroblasts and hemopoetic cell-lines (1994) (0)
[The Otto-Braun-Falco-Stipendium: A German-Polish success story]. (2012) (0)
Functional activity of granulocytes from patients with neutrophilic dermatoses (1984) (0)
Detection of Groα gene expression in pscriatic lesions (1994) (0)
[How do keratolytics work?]. (1979) (0)
Subject Index Vol. 120, Suppl. 1, 1999 (1999) (0)
In-vivo effects of chronic IL-8 stimulation in rats (1994) (0)
7.1 Psoriasis vulgaris (2002) (0)
Regulation of CXCR2 expression in human keratinocytes: Correlation with proliferation and differentiation (1998) (0)
Tacrolimus Ointment (Protopic ) for Atopic Dermatitis (2004) (0)
[Filiform keratosis]. (1994) (0)
[The enzyme release by Trichophyton rubrum is dependent on nutritional substance supply]. (1991) (0)
Human leucocyte elastase can impair epidermal intercellular cohesion (1993) (0)
The Treatment of Atopic Dermatitis and Other Dermatoses with Leukotriene Antagonists (2004) (0)
2482 – Toxicological and Pharmacological Aspects of Topical Agents in Relation to Epidermis (1978) (0)
Lack of imprinting found in a large cohort of type I psoriasis family members (1998) (0)
Author Index, 6th International Psoriasis Symposium (1995) (0)
Morphologie des Stratum corneum (2004) (0)
REVIEW OF THE GERMAN DERMATOLOGICAL LITERATURE 1967 * (1970) (0)
[Comment on the contribution by S. Pingel: Homeopathy--basic principles and applications in dermatology. A word on homeopathy]. (1994) (0)
3 MECHANISMS OF HOST DEFENSE IN HUMAN SKIN : ROLE OF ANTIMICROBIAL PEPTIDES (1999) (0)
Abstracts of the 6th International Psoriasis Symposium (Part 1 of 3) (1995) (0)
Skin changes in successfully treated Hodgkin's disease patient (1997) (0)
Current status in melanoma treatment (1993) (0)
12.2 Psoriasis (1992) (0)
KERATINIZATION OF SUBCULTURED KERATINOCYTES (1974) (0)
[Cutaneous liquefaction necrosis caused by temporary external pacemakers]. (1985) (0)
[Fluoride tablets for caries prevention in children with neurodermatitis and cow's milk allergy?]. (1996) (0)
Epidermal Response to Antihyperkeratotic Agents (1979) (0)
Linkage of psoriasis to the MHC and evidence for additional loci in a large cohort (International Psoriasis Genetics Consortium). (2002) (0)
[Comment of the German Dermatologic Society to the therapeutic procedures of a dermatologist]. (1993) (0)
Platelet-derived eosinophil-chemotactic cytokine rantes (1993) (0)
Antileukoprotease in human keratinocyte derived cell lines (1993) (0)
023 Identification of rantes and GM-CSF as eosinophil attractants produced by stimulated dermal fibroblasts (1996) (0)
[On cell reduplication in the exocrine sweat glands before and after stripping]. (1967) (0)
N12. Psoriasis (1997) (0)
[Merkel cell tumor of the skin]. (1997) (0)
Etanercept (Enbrel )-An Update (2005) (0)
[Unusual circinary variant of generalized granuloma anulare]. (1996) (0)
Modulation of polymorphonuclear leucocyte (PMN) chemotaxis and superoxide anion production by wheat germ agglutinin (WGA) in skin diseases with PMN hyper-responsiveness (1984) (0)
Expression of eotaxin in allergic late phase reaction: Evidence for a T-cell independent eosinophil activation pathway (1998) (0)
Contents Vol. 205, 2002 (2002) (0)
Eotaxin, MCP-4, MCP-3, RANTES and GMCSF gene expression in skin fibroblasts and keratinocytes: Implications for eosinophil skin infiltration (1998) (0)
[The effect of the coagulation and fibrinolysis system on wound healing and thrombus organization]. (1978) (0)
[Dermatologists as directors of a dermatologic specialty clinic?]. (1992) (0)
Highly purified omega-3-polyunsaturated fatty acids for topical treatment in psoriasis — Results of a double-blind, placebo-controlled multicentre study (1993) (0)
Effects of alkaline on horny layer cellularity (1977) (0)
[Cell differentiation in the stratum granulosum: electron microscopic and autoradiographic incorporation studies using 3H-histidine]. (1972) (0)
Localization of a psoriasis vulagaris susceptibility allele on specific ancestral HLA-haplotypes (1998) (0)
[Epidermal regeneration: aspects of cell kinetics]. (1972) (0)
Electronic processing of papers (2003) (0)
A new optimized test to detect 5-S-cysteinyldopa (5-S-CD) in serum of melanoma patients as a tool of tumor progression: 307 (1997) (0)
Atopic dermatitis versus infantile eczema. Discussion (2001) (0)
Lockable tissue punch for taking tissue biopsies from tissues (1979) (0)
Pioneers in dermatology and venereology: an interview with Prof. Enno Christophers (2019) (0)
[Rothmund-Thomson syndrome]. (2020) (0)
Acknowledgement to Referees for Dermatology 2002 (2002) (0)
Basic versus clinical research: ADR closes the gap (2003) (0)
[Short report on the seventh Psoriasis Professional Meeting, Bad Bentheim, March 14-15, 1997]. (1997) (0)
From the Editor (1998) (0)
[Working Group on Dermatological Prevention (ADP) e. V]. (2014) (0)
effective against bacteria, viruses mycota and cosmetic preparations containing Vertebratenproteine (1996) (0)
Contents, Vol. 179, Supplement 1, 1989 (1989) (0)
[From dermatology into cosmetics. Chance or risk?]. (2002) (0)
Characterization of HLA-haplotypes in familial Psoriasis (2001) (0)
Distribution of interleukin 8 immunoreactivity in malignant tumors of human skin (1994) (0)
Contents, Vol. 168, 1984 (1984) (0)
Characterization of serine proteases producted by HaCaT cells (1994) (0)
4- (E) - and 4- (Z) -7-methyl-9- (2,6,6trimethyl-1-cyclohexen-1-yl) -nona-2,4,6,8tetraencarbonsaeure, and their derivatives containing them preparations (1974) (0)
Die Gründung der European Skin Research Foundation (ESRF) (2008) (0)
Immunosuppression of skin diseases (1998) (0)
Groα and IL-8 cause hyperproliferation in raft culture (1998) (0)
Linkage of familial psoriasis to the HLA-B and HLA-C region of the major histocompability complex (MHC) (1997) (0)
Pichia pastoris, an alternative for expression of epidermal protease inhibitors (1998) (0)
[Skin manifestations in human yersiniosis (author's transl)]. (1981) (0)
Human keratinocytes and cutaneous innate immunity (2000) (0)
Organisation, regulatory sequences and transcriptional regulation of the genes encoding the human eosinophil chemoattractants eotaxin and MCP4 (1998) (0)
Jenisch Corneodesmosin gene polymorphism S . Koch demonstrates strong linkage disequilibrium (1999) (0)
Chicken antibodies specific for stratum corneum chymotryptic enzyme (1998) (0)
[Autoantibodies in bullous dermatoses]. (1970) (0)
[Granular degeneration in naevus verrucosus bilateralis. A morphologic and functional study]. (1969) (0)
Treatment of Postherpetic Neuralgia (2004) (0)
IL-4 and IL-13 induce eotaxin in dermal fibroblasts: a possible mechanism of eosinophil recruitment in TH2 type cytokine mediated skin inflammation (1998) (0)
The Use of Alefacept in the Treatment of Psoriasis (2003) (0)
Wolfram Sterry –in memoriam (2020) (0)
Genomic cloning and gene regulation of the skin-derived antibiotic peptide HBD-2 (1998) (0)
Contents, Vol. 172, 1986 (2004) (0)

This paper list is powered by the following services:

Other Resources About Enno Christophers

en.wikipedia.org

What Schools Are Affiliated With Enno Christophers?

Enno Christophers is affiliated with the following schools:

Kiel University